Abstract:ABSTRACT Numerous viruses have been found to exploit glycoconjugates expressed on human cells as their initial attachment factor for viral entry and infection. The virus-cell glycointeractome, when characterized, may serve as a template for antiviral drug design. Heparan sulfate proteoglycans extensively decorate the human cell surface and were previously described as a primary receptor for human metapneumovirus (HMPV). After respiratory syncytial virus, HMPV is the second most prevalent respiratory pathogen causing respiratory tract infection in young children. To date, there is neither vaccine nor drug available to prevent or treat HMPV infection. Using a multidisciplinary approach, we report for the first time the glycointeractome of the HMPV fusion (F) protein, a viral surface glycoprotein that is essential for target-cell recognition, attachment, and entry. Our glycan microarray and surface plasmon resonance results suggest that Galβ1-3/4GlcNAc moieties that may be sialylated or fucosylated are readily recognized by HMPV F. The bound motifs are highly similar to the N -linked and O- linked glycans primarily expressed on the human lung epithelium. We demonstrate that the identified glycans have the potential to compete with the cellular receptors used for HMPV entry and consequently block HMPV infection. We found that lacto- N -neotetraose demonstrated the strongest HMPV binding inhibition in a cell infection assay. Our current findings offer an encouraging and novel avenue for the design of anti-HMPV drug candidates using oligosaccharide templates. IMPORTANCE All cells are decorated with a dense coat of sugars that makes a sugar code. Many respiratory viruses exploit this sugar code by binding to these sugars to cause infection. Human metapneumovirus is a leading cause for acute respiratory tract infections. Despite its medical importance, there is no vaccine or antiviral drug available to prevent or treat human metapneumovirus infection. This study investigates how human metapneumovirus binds to sugars in order to more efficiently infect the human host. We found that human metapneumovirus binds to a diverse range of sugars and demonstrated that these sugars can ultimately block viral infection. Understanding how viruses can take advantage of the sugar code on our cells could identify new intervention and treatment strategies to combat viral disease.

Glycan Nanostructures of Human Coronaviruses

Glycan Nanostructures of Human Coronaviruses

New Progress of Glycosylation in Coronaviruses

The Mechanism of Glycosylation in SARS-CoV-2 Infection and Application in Drug Development

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation

The glycosylation in SARS-CoV-2 and its receptor ACE2

Structural basis of glycan interaction in gastroenteric viral pathogens

Glycan Recognition in Human Norovirus Infections

Comparing the Nucleocapsid Proteins of Human Coronaviruses: Structure, Immunoregulation, Vaccine, and Targeted Drug

Molecular recognition in the infection, replication, and transmission of COVID-19-causing SARS-CoV-2: an emerging interface of infectious disease, biological chemistry, and nanoscience

Structural basis for human coronavirus attachment to sialic acid receptors

Novel insights into the host cell glycan binding profile of human metapneumovirus

Combating DC-SIGN-mediated SARS-CoV-2 dissemination by glycan-mimicking polymers

Antiviral Activity of Nanomaterials Against Coronaviruses.

Synthetic O-acetylated sialosides facilitate functional receptor identification for human respiratory viruses

Antiviral Activity of Nanomaterials against Coronaviruses

Nano-therapeutic strategies to target coronavirus

Host Cell Glycocalyx Remodeling Reveals SARS-CoV-2 Spike Protein Glycomic Binding Sites

Synthetic O -Acetyl- N -glycolylneuraminic Acid Oligosaccharides Reveal Host-Associated Binding Patterns of Coronaviral Glycoproteins

Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2

Binding of the SARS-CoV-2 spike protein to glycans